Caladiv (Skin) (50 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Nirix Derma. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Calamine, Aloe Vera,Light Liquid Parafin. This drug comes in the form of Lotion. The general packing available for this medicine consists of 50 ml and is priced at Rs 78 (arround $1.092 US Dollar)
Calamine Indication (Prescribed for or used as): Soothing and protective agent. Sunburn, insect bite, urticaria and contact dermatitis.
For more details on Calamine, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Calamine..
Aloe Vera Indication (Prescribed for or used as):
For more details on Aloe Vera, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Aloe Vera..
Light Liquid Parafin Indication (Prescribed for or used as):
For more details on Light Liquid Parafin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Light Liquid Parafin..
Caladiv (Skin) (50 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Caladiv (Skin) (50 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Calamine-8% w/w Aloe Vera-10% Light Liquid Parafin-10% w/w). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.